Sanj K Patel - Net Worth and Insider Trading

Sanj K Patel Net Worth

The estimated net worth of Sanj K Patel is at least $6 Million dollars as of 2025-07-03. Sanj K Patel is the CHAIRMAN & CEO of Kiniksa Pharmaceuticals International PLC and owns about 206,469 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $6 Million. Details can be seen in Sanj K Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sanj K Patel has not made any transactions after 2025-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Sanj K Patel

To

Sanj K Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sanj K Patel owns 4 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) , Syros Pharmaceuticals Inc (SYRS) , and BioCryst Pharmaceuticals Inc (BCRX) among others .

Click here to see the complete history of Sanj K Patel’s form 4 insider trades.

Insider Ownership Summary of Sanj K Patel

Ticker Company Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2025-05-28 director & 10 percent owner & Chairman & CEO
SYRS Syros Pharmaceuticals Inc 2016-06-29 director
BCRX BioCryst Pharmaceuticals Inc 2015-09-25 director
LIMIT LIMIT 2014-02-17 director

Sanj K Patel Latest Holdings Summary

Sanj K Patel currently owns a total of 1 stock. Sanj K Patel owns 206,469 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of May 28, 2025, with a value of $6 Million.

Latest Holdings of Sanj K Patel

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals International PLC 2025-05-28 206,469 27.44 5,665,509

Holding Weightings of Sanj K Patel


Sanj K Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Sanj K Patel has made a total of 10 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 86,270 shares on May 28, 2025, which brought Sanj K Patel around $2 Million.

Insider Trading History of Sanj K Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sanj K Patel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sanj K Patel Ownership Network

Ownership Network List of Sanj K Patel

No Data

Ownership Network Relation of Sanj K Patel

Insider Network Chart


Sanj K Patel Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Sanj K Patel is the director & 10 percent owner & Chairman & CEO of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Business Officer Eben Tessari , Interim CFO Mark Ragosa , and Group VP & Rilonacept GM Ross Moat .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Sanj K Patel made 8 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 408,607. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 244,593 shares made by Eben Tessari , a net sale of 246,546 shares made by Mark Ragosa , and a net sale of 211,750 shares made by Ross Moat .

In summary, during the past 3 months, insiders sold 522,197 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 522,197 shares. During the past 18 months, 1,297,332 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,297,332 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Sanj K Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Sanj K Patel. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sanj K Patel's mailing address is: Hamilton D0 Hm11.